Healthpeak Properties upgraded by Exane BNP Paribas with a new price target

4/26/24 1:33:41 PM ET

Real Estate Investment Trusts

Real Estate

Exane BNP Paribas upgraded Healthpeak Properties from Neutral to Outperform and set a new price target of $21.00 from $19.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DOC

Date	Price Target	Rating	Analyst
1/15/2025	$25.00	Equal-Weight → Overweight	Morgan Stanley
10/21/2024	$20.00 → $28.00	Hold → Buy	Deutsche Bank
5/3/2024		Neutral → Outperform	Wedbush
4/26/2024	$19.00 → $21.00	Neutral → Outperform	Exane BNP Paribas
4/22/2024	$22.00	Buy	Mizuho
4/1/2024	$18.00 → $25.00	Underperform → Buy	BofA Securities
3/25/2024	$19.00	Equal Weight	Wells Fargo
3/8/2024	$21.00	Outperform	RBC Capital Mkts